Lupin Limited — Updates, 02-04-2026: Press Release
02-04-2026 | 10:58 am
02-04-2026 | 10:58 am
Lupin completed its acquisition of VISUfarma, a European ophthalmology company. This significantly expands Lupin's eye care portfolio to over 60 products and strengthens its European market presence. VISUfarma previously generated €53m (5.3 Cr) in revenue. Strategic move for specialty care.
No comments yet. Be the first to comment!
